News From Africa

Africa: Malaria Vaccine Becomes First to Achieve WHO-specified 75% Efficacy Goal


[Oxford University] Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.

Africa: RTS,S Malaria Vaccine Reaches More Than 650 000 Children in Ghana, Kenya and Malawi Through Groundbreaking Pilot Programme

Previous article

Africa: Draw the Line This World Malaria Day, Urges WHO #ZeroMalaria

Next article

You may also like


Leave a Reply